Cambridge Investment Research Advisors, Inc. Annexon, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Annexon, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,700 shares of ANNX stock, worth $33,705. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,700
Previous 10,700
-0.0%
Holding current value
$33,705
Previous $21,000
23.81%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ANNX
# of Institutions
140Shares Held
96.5MCall Options Held
0Put Options Held
63.4K-
Satter Management Co., L.P.7.41MShares$23.3 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$22.1 Million0.66% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$20.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$19.8 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$16.9 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $150M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...